Abnova Corporation, Taiwan

Last updated: 13.02.2014

abnova-logo-1.jpgFounded in 2002 as a high throughput and industrial-scale antibody manufacturing, Abnova has diversified and established fully integrated technologies from design to production to catapult innovation and growth in the diagnostic industry. Abnova’s new capabilities include rabbit monoclonal antibody, FISH probe, nanoparticle/nanostructure synthesis, microfluidics, optics, electronics, and automations.  Abnova’s facility is ISO13485 and GMP certified for bioreagent and instrument development and manufacturing. Abnova has successfully developed and partnered with global companies in companion diagnostic of lung cancer, point-of-care screening of diabetes, and non-invasive prenatal diagnosis of fetal cell.  Abnova also provides these effective turnkey solutions as services to collaborators and customers worldwide.

Contact Information

Add: 9th Fl., No.108, Jhouzih St., 
Neihu District. Taipei City, Taiwan 114

Tel: +886-2-8751-1888
Fax: +886-2-8751-9489

Email: sales@abnova.com


We use cookies to ensure that we give you the best experience on our site. For more info click here